Concepedia
Statistics
Publications
28
Citations
2K
H-Index
23
Active since
1999
Affiliations
Universitätsklinikum Würzburg(Current)
Comprehensive Cancer Center Mainfranken
Bayer (Germany)
University of Oxford
University Medical Center Utrecht
Cyrus Sayehli is an author at Universitätsklinikum Würzburg specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
1999–2025
Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma
Andreas Viardot, Marie-Elisabeth Goebeler, Svenja Neumann et al. · Blood · 2016 · 366 citations · Full text
Life Sciences, Hematology, Immunology +16
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schüler, Byoung Chul Cho, Cyrus Sayehli et al. · The Lancet Oncology · 2019 · 174 citations
Medicine, Oncology, Pharmacology +11
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +15
Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings
Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich et al. · Immunotherapy · 2020 · 144 citations · Full text
Medicine, Oncology, Pharmacology +17
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text
Medicine, Critical Care Nursing, Critical Care Medicine +6
1–5 of 28